Oncomed Pharmaceuticals Inc
SEC CIK 1302573 · OMED · last insider filing 2019-04-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lasersohn Jack W | Director | filed 2013 - 2019 |
| Root Jonathan D | Director | filed 2013 - 2019 |
| Karsen Perry A | Director | filed 2016 - 2019 |
| Pakianathan Deepika | Director | filed 2013 - 2019 |
| Lewicki John A. | Director · President and CEO | filed 2013 - 2019 |
| Wyzga Michael S | Director | filed 2013 - 2018 |
| Scots-Knight Denise | Director | filed 2013 - 2018 |
| Winningham Rick E | Director | filed 2015 - 2018 |
| Hastings Paul J | Director · President & CEO | filed 2013 - 2017 |
| Lasky Laurence | Director | filed 2013 - 2017 |
| Gould Terry P | Director | filed 2013 - 2016 |
| Woody James N. | Director | filed 2013 - 2013 |
| Broderick James W. | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hager Alicia J. | VP & General Counsel | filed 2013 - 2019 |
| Li Yvonne | See Remarks | filed 2018 - 2019 |
| Stagg Robert | See Remarks | filed 2018 - 2019 |
| Gurney Austin | See remarks | filed 2013 - 2018 |
| Patel Sunil | See Remarks | filed 2013 - 2018 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | filed 2013 - 2017 |
| Dupont Jakob | SVP & Chief Medical Officer | filed 2013 - 2016 |
| Waddill William D. | SVP & Chief Financial Officer | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.